$PACK

Ranpak Holdings Corp. (PACK): Results of Operations and Financial Condition

Ranpak Holdings Corp. (PACK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a04pack-202606xex99x1.htm EX-99.1 Document Exhibit 99.1 Ranpak Holdings Corp. Reports Second Quarter 2026 Financial Results • Net revenue for the second quarter increased 14.0% year over year to $105.2 million and increased 12.2% year over year on a constant currency ba

Original reporting
Published Jul 30, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 11:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PACK
Bullish
medium confidence
Mentioned
$PACK
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PACKBullishMed
01

Why it matters

The key trade-relevant items are the acceleration in automation revenue and AEBITDA growth, contrasted with a decline in PPS system placements. Liquidity is described as strong with no revolver borrowings and substantial term-facility balance.

02

Market read

A fresh quarterly print with segment mix signals (automation up sharply, PPS placements down) and a reiterated expectation to achieve full-year guidance.

03

What to watch

Net loss widened slightly to $7.9M and the results include non-cash warrant-related impacts; investors may adjust for warrant effects and focus on cash flow and longer-term PPS placement trends.

Relevance 7/10Novelty 7/10Timing: filed pre-market today (2026-07-30) with Q2 2026 financial results

Background

This is an SEC 8-K filing with Exhibit 99.1 reporting Ranpak’s second quarter 2026 operating results and liquidity position.

Company-level read

Ticker impact

$PACKBullishMedium confidence
Context

Ranpak reported Q2 2026 results: net revenue rose 14% to $105.2M, AEBITDA rose 15.8% to $19.1M, and PPS placements fell 2.3% to 141.7k.

Expected impact

Likely positive bias on automation strength, partially offset by the PPS placement decline; net effect depends on how investors weigh mix shift versus installed-base momentum.

Evidence & confidence

The filing provides multiple directional datapoints (automation +139.4% constant currency, AEBITDA +15.8%, PPS placements -2.3%) plus liquidity and facility details, but it does not include explicit full-year guidance numbers beyond reiterating expectations.

Market effects

Signals demand resilience in automation and void-fill/wrapping, while PPS installed-base placements show slower replacement cadence.

Mentions EMEA growth exceeding expectations, implying regional strength could offset softness elsewhere.

E-commerce and industrial supply-chain packaging demand read-through, with Cold Chain positioning referenced as a longer-term portfolio expansion.

Counterpoint

PPS system placements declined 2.3% YoY to 141.7k, which could indicate slower installed-base expansion even as automation revenue grows.

Key entities

  • Ranpak Holdings Corp.

    Reported Q2 2026 net revenue, AEBITDA, PPS system placements, and liquidity details in an SEC 8-K.

  • Omar Asali

    Chairman and CEO who commented on automation momentum and expectations for the year.

  • Protective Packaging Solutions (PPS) system

    Installed-base metric declined 2.3% YoY to about 141.7k machines at June 30, 2026.

Related articles

$PACKMed

Ranpak Q2 Earnings Call Highlights

Ranpak (NYSE:PACK) reported Q2 results on an earnings call. Management said constant-currency net revenue rose 15.4% in Europe and Asia-Pacific, with automation revenue up 103.7% and PPS volumes up 2.4% YoY. Adjusted EBITDA increased $2.6M to $19.1M; gross margin improved 150 bps. Ranpak expects automation adjusted EBITDA breakeven late 2026 and EBITDA-positive in 2027.

$PACKMedAI 8/10

Ranpak (NYSE:PACK) Reaches New 1

Ranpak Holdings (NYSE:PACK) hit a new 52-week high on Tuesday, trading up to $6.67 and last at $6.62 versus a prior close of $6.28. The article cites recent analyst actions including UBS and Cantor reiterating “overweight,” while Wall Street Zen raised PACK to “hold.” MarketBeat shows a “Moderate Buy” consensus and $6.83 target. In its April 30 earnings, Ranpak reported EPS of -$0.12 and revenue of $101.2M.

$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

$MDTMedAI 8/10

Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?

Medtronic (MDT) and Tenet Healthcare (THC) present distinct growth prospects. MDT reported its highest annual revenue growth in a decade, driven by cardiac ablation solutions and investments in innovation. THC saw a 52.2% increase in adjusted EPS and 6.8% revenue growth, with margin expansion in hospitals. Investors must choose between MDT's innovation-led recovery and THC's operational improvements.